Ahmet Nedim Kahraman

Prof. Ahmet Nedim Kahraman

Radiology, Fatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi, Istanbul, İstanbul, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2018 in European Journal of Breast Health
Verified
Journal Article
Closed access
OSOzgur Sarica
Ozgur Sarica
AKAhmet Nedim Kahraman
Ahmet Nedim Kahraman
EOEnis Ozturk
Enis Ozturk
MTMemik Teke
Memik Teke
Eur J Breast Health AVES | Copyright © 2017 Türkiye Meme Hastalıkları Dernekleri Federasyonu |

20 December 2021 in Tuberk Toraks
Verified
Journal Article
Closed access
AVAhmet Vural
Ahmet Vural
AKAhmet Nedim Kahraman
Ahmet Nedim Kahraman
To date, there is limited data on the long-term changes in the lungs of patients recovering from coronavirus (COVID-19) pneumonia. In order to evaluate pulmonary sequelae, it was planned to investigate fibrotic changes observed as sequelae in lung tissue in 3-6-month control thorax computerized tomography (CT) scans of moderate-to-severe COVID-19 pneumonia survivors. A total of 84 patients (mean age: 67.3 years ±15) with moderate-to-severe pneumonia on chest tomography at the time of diagnosis were included in the study, of which 51 (61%) were males and 33 (39%) were females. Initial and follow-up CT scans averaged 8.3 days ± 2.2 and 112.1 days ± 14.6 after symptom onset, respectively. Participants were recorded in two groups as those with and without fibrotic-like changes such as traction bronchiectasis, fibrotic - parenchymal bands, honeycomb appearance according to 3-6 months follow-up CT scans. Differences between the groups were evaluated with a two-sampled t-test. Logistic regression analyzes were performed to determine independent predictive factors of fibrotic-like sequelae changes. On follow-up CTs, fibrotic-like changes were observed in 29 (35%) of the 84 participants (Group 1), while the remaining 55 (65%) showed complete radiological recovery (Group 2). With logistic regression analysis, hospital stay of 22 days or longer (OR: 4.9; 95% CI: 20, 32; p< 0.05) and a CT score of 15 or more at diagnosis (OR: 2.2; 95% CI: 13.5, 18; p< 0.05) were found to be an independent predictor for sequelae fibrotic changes in lung tissue. More than one-third of patients who survived COVID-19 pneumonia had fibrotic-like sequelae changes in the lung parenchyma. These changes were found to be associated with the presence of severe pneumonia at the time of diagnosis and longer hospital stay.

8 March 2024 in Tobacco Induced Diseases
Verified
Journal Article
Open access
KGKamber Goksu
Kamber Goksu
AVAhmet Vural
Ahmet Vural
AKAhmet Nedim Kahraman
Ahmet Nedim Kahraman
IAIsil K. Aslan
Isil K. Aslan
Introduction: Smoking is one of the most important preventable causes of cardiovascular diseases. Vascular disease caused by smoking is associated with vascular endothelial damage, platelet aggregation, and adhesion. In our study, we examined the effect of chronic smoking on vessel wall...

18 April 2023 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
AKAslinur Keles
Aslinur Keles
FOFeyza Unlu Ozkan
Feyza Unlu Ozkan
EGEsra Giray
Esra Giray
PKPapatya Keles
Papatya Keles
BKBurak KARİP
Burak KARİP
IAİlknur Aktas
İlknur Aktas


30 November 2020 in HCA Healthcare Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AVAhmet Vural
Ahmet Vural
AKAhmet Nedim Kahraman
Ahmet Nedim Kahraman
Introduction: The clinical manifestations of the worldwide pandemic, which began in mainland China in December 2019, were very similar to viral pneumonia and defined as Coronavirus disease 2019 (COVID-19). Complications such as acute respiratory distress syndrome (ARDS), acute cardiac tissue damage, secondary infections, isolated coagulopathy and pulmonary embolism have been reported with COVID-19 disease. Clinical Findings: A 79-year-old woman admitted to the emergency room (ER) had complaints of fever and cough. The patient was admitted to the ER with the suspicion of COVID-19. Samples were collected with a nasopharyngeal swab and confirmed as COVID-19. In addition, a chest CT examination was performed. In the first evaluation after admittance, the D-dimer value was measured as 450 μg/L. In the follow-up of the patient, on the 18th day, increased respiratory distress and high D-dimer level (7893 μg/L) were detected in the laboratory findings. Outcomes: A chest CT scan had ground-glass opacities compatible with COVID-19 pneumonia. A giant cavitary lesion was detected following the development of pulmonary embolism after COVID-19 disease. Conclusions: In rare cases of COVID-19 cavitation development may occur after pulmonary infarction. In addition, it should be remembered that emphysema, giant bulla and pneumothorax may develop in COVID-19 pneumonia cases undergoing HFNC oxygen therapy. We present a case of a giant cavitary lesion that developed following a COVID-19-related pulmonary embolism.